📅 Updated July 2026 · ⏱ 12 min read · 🇬🇧 UK-focused · Updated with 2025 Nature Metabolism trial
📋 Disclosure and compliance: This guide is written by Charge Products (Big Idea Services Ltd, Co. No. 11645389) — a UK in-house supplement manufacturer. We sell NMN + Niacin B3 Dual Pathway Capsules. We have commercial interest in this subject. This product contains Nicotinic Acid (flush B3) — the niacin flush (warmth, redness, tingling) is expected. No authorised EU/UK health claims exist for NMN. Authorised B3/Niacin health claims listed in full below. Food supplement — not a medicine. Consult your GP if on prescription medication, particularly statins.
⚡ Direct Answer — NMN and Nicotinic Acid Dual Pathway
The body has three NAD+ biosynthetic pathways — salvage (~85%), Preiss-Handler (Nicotinic Acid route) and de novo (tryptophan). A 2025 trial in Nature Metabolism (Christen et al.) found that NMN appears to raise NAD+ sustainably by converting to Nicotinic Acid in the gut and entering the Preiss-Handler pathway — not the salvage pathway as previously assumed. This makes combining NMN with exogenous Nicotinic Acid mechanistically interesting: both feed the same Preiss-Handler route simultaneously. No combined human RCT exists — this is a mechanistic hypothesis. Nicotinic Acid (flush B3) is distinct from Nicotinamide (non-flush) — they use different pathways. The flush is a prostaglandin response, not toxicity. Food supplement — not a medicine.
📋 In This Guide:
- The Three NAD+ Biosynthetic Pathways
- The 2025 Nature Metabolism Update — How NMN Actually Works
- Nicotinic Acid vs Nicotinamide — Why the Distinction Matters
- The Niacin Flush — What It Is and What It Is Not
- The Dual Pathway Rationale — NMN + Nicotinic Acid
- Human Trial Evidence for Each Component
- Authorised B3/Niacin Health Claims
- Practical Guide
- Products
- FAQ
Section 1 — The Three NAD+ Biosynthetic Pathways
To understand why NMN + Nicotinic Acid is mechanistically interesting, you first need to understand that your body does not have one route to making NAD+ — it has three, each starting from different precursors and running through different enzymatic steps.
⚗️ THE THREE NAD+ BIOSYNTHETIC PATHWAYS
1 — Salvage Pathway (~85% of NAD+)
Nicotinamide (NAM) → NMN → NAD+
Rate-limiting enzyme: NAMPT · Recycles NAM from NAD+-consuming enzymes (sirtuins, PARPs, CD38) · Produces approximately 85% of the body's NAD+
2 — Preiss-Handler Pathway
Nicotinic Acid (NA) → NAMN → NAAD → NAD+
Rate-limiting enzyme: NAPRT · Uses dietary Nicotinic Acid as substrate · Runs through deamidated intermediates (NAMN, NAAD) before reaching NAD+ · Named after Jack Preiss and Philip Handler who first described it
3 — De Novo Pathway (least significant)
Tryptophan → Quinolinic Acid → NAMN → NAD+
Converts dietary tryptophan through the kynurenine pathway · Converges with Preiss-Handler at NAMN · Least efficient and least significant of the three routes
Source: Yu et al. (2024, PMC11473484) · Yang et al. (2024, Food Frontiers) · Igarashi et al. (2023, J Cell Mol Immunol)
The salvage pathway dominates — producing approximately 85% of the body's NAD+. But the Preiss-Handler pathway, while a smaller contributor under normal conditions, is the route that becomes particularly relevant when we consider how NMN works in the body. This is where the 2025 mechanistic finding becomes important. Educational context — food supplement, not a medicine.
Section 2 — The 2025 Nature Metabolism Update
This is the most significant mechanistic update in NMN research in 2025 — and it directly informs why the NMN + Nicotinic Acid combination is more interesting than it previously appeared.
📚 Christen et al. (2025, Nature Metabolism)
First human trial directly comparing NMN, NR and Nicotinamide (Nam) in the same subjects
✅ NMN sustainably doubled circulating NAD+ over 14 days
✅ NR also sustainably doubled NAD+ via the same mechanism
⚠️ Nicotinamide (Nam) did NOT produce the same sustained NAD+ elevation
🔬 NMN and NR raise NAD+ via the Preiss-Handler pathway — through gut microbial conversion to Nicotinic Acid
The key mechanistic finding: when you take NMN orally, gut microbes appear to convert it to Nicotinic Acid (NA), which then enters the Preiss-Handler pathway to raise NAD+. NMN is not entering the salvage pathway directly as the simpler model assumed. (Christen et al., 2025, Nature Metabolism)
⚠️ What This Finding Does and Doesn't Mean
What it means: The Preiss-Handler pathway — previously considered secondary — may be more important to NMN's NAD+-raising effect than previously understood. Individual gut microbiome composition may influence how well NMN works for a given person — explaining why some users notice clear effects and others notice nothing.
What it doesn't mean: That NMN is "just niacin." The conversion process and the downstream NAD+ elevation are real and well-documented. This is a mechanistic finding about route — not a finding that NMN is ineffective. Educational context — not a health claim.
Section 3 — Nicotinic Acid vs Nicotinamide — Why the Distinction Matters
This is the distinction most brands blur — and it is genuinely important for understanding the pathway rationale.
| Property | Nicotinic Acid (NA · Flush B3) | Nicotinamide (NAM · Non-Flush B3) |
|---|---|---|
| Chemical name | Pyridine-3-carboxylic acid | Pyridine-3-carboxamide |
| NAD+ pathway | ✅ Preiss-Handler pathway | Salvage pathway |
| Niacin flush | ⚠️ Yes — prostaglandin-mediated | ✅ No flush |
| Pathway alignment with NMN | ✅ Same pathway as NMN (Preiss-Handler via Christen 2025) | ⚠️ Different pathway — salvage |
| Sustained NAD+ elevation | ✅ Yes — Preiss-Handler produces sustained elevation | ⚠️ Acute rise — not sustained per Christen 2025 |
| Authorised EU/UK claims | ✅ 8 authorised claims (same as Niacin) | ✅ 8 authorised claims (same as Niacin) |
| In our products | NMN + Niacin B3 Dual Pathway capsules | NAD Max capsules |
The distinction is not just about the flush. It is about which biosynthetic pathway each form enters — and based on the Christen 2025 finding, Nicotinic Acid enters the same Preiss-Handler route that NMN appears to be utilising. Nicotinamide enters the salvage pathway — a different route, also valid, but a different mechanistic rationale for combination. Educational context — food supplement, not a medicine.
Section 4 — The Niacin Flush — Honest Assessment
🔬 What Causes the Flush — The Biology
Nicotinic Acid activates GPR109A receptors on skin Langerhans cells (immune cells in the skin), triggering prostaglandin D2 (PGD2) release. PGD2 causes vasodilation of skin capillaries — producing the characteristic warmth, redness and tingling across the face, neck and chest. This is a prostaglandin-mediated vascular response — not a metabolic or hepatic effect.
✅ What the Flush Is NOT
❌ Not a sign of liver damage
Liver concerns relate to high-dose sustained-release Nicotinamide — not standard NA at supplement doses
❌ Not dangerous at 100mg
Our combination contains 100mg NA — significantly below cardiovascular trial doses of 500–2,000mg
❌ Not permanent
Typically diminishes significantly within 2–4 weeks as GPR109A receptor downregulation occurs
❌ Not an allergic reaction
Pharmacological response — expected and documented. Different mechanism from allergy.
⚠️ How to Minimise the Flush
| Approach | Evidence |
|---|---|
| Take with food containing fat | ✅ Most effective — fat slows NA absorption and attenuates prostaglandin release |
| Take consistently every day | ✅ GPR109A receptor downregulation — flush diminishes within 2–4 weeks |
| Start with half capsule for first week | ✅ 50mg NA produces milder flush than 100mg — useful for first exposure |
| Avoid on empty stomach | ✅ Fasted state significantly increases flush intensity |
| Avoid hot drinks immediately after | ⚠️ Heat may compound vasodilation — practical tip rather than clinical evidence |
Section 5 — The Dual Pathway Rationale
Here is the mechanistic case for combining NMN with Nicotinic Acid specifically — and the honest caveats around it.
⚗️ HOW THE DUAL PATHWAY STACK WORKS — PROPOSED MECHANISM
NMN Route (Christen 2025)
NMN (oral) → gut microbial conversion → Nicotinic Acid (NA) → NAPRT enzyme → NAMN → NMNAT enzyme → NAAD → NAD synthetase → NAD+ via Preiss-Handler ✅
Nicotinic Acid Route (Direct)
Nicotinic Acid 100mg (direct) → NAPRT enzyme → NAMN → NMNAT enzyme → NAAD → NAD synthetase → NAD+ via Preiss-Handler ✅
Both routes converge on the same Preiss-Handler pathway — NMN feeding it indirectly via gut conversion, Nicotinic Acid feeding it directly. The hypothesis: combined, they may provide greater substrate availability to this pathway than either alone. This is a mechanistic hypothesis — no combined human RCT has been published. Mechanism based on Christen et al. 2025, Nature Metabolism and Yu et al. 2024, PMC11473484.
⚠️ The Honest Caveat
No published human RCT has directly tested NMN + Nicotinic Acid as a combined intervention. The dual pathway rationale is mechanistically coherent based on the Christen 2025 finding — but it remains a hypothesis. It should not be presented as a proven superior approach to taking NMN alone. Educational context — food supplement, not a medicine.
Section 6 — Human Trial Evidence
NMN — Published Human Trials
| Trial | Dose | Duration | Key Finding |
|---|---|---|---|
| Yoshino et al. 2021 (PubMed 33888596) | 250mg/day | 10 weeks | Improved muscle insulin sensitivity in postmenopausal women ✅ |
| Liao et al. 2021 (PubMed 34238308) | 300–600mg/day | 6 weeks | Improved aerobic capacity in runners ✅ |
| Yi et al. 2023 (PubMed 36482269) | 300mg/day | 60 days | Improved physical performance · middle-aged adults ✅ |
| Christen et al. 2025 (Nature Metabolism) | Head-to-head | 14 days | NMN sustainably doubled NAD+ · Preiss-Handler mechanism ✅ |
Nicotinic Acid (B3/Niacin) — Evidence Base
Nicotinic Acid is one of the most extensively studied forms of vitamin B3 — with a clinical research history spanning decades. At the supplement doses in our combination (100mg), the evidence base covers: reliable Preiss-Handler pathway NAD+ elevation, 8 authorised EU/UK health claims for niacin covering energy metabolism, nervous system function, psychological function, skin and mucous membrane maintenance. The high-dose cardiovascular evidence (500–2,000mg) is a separate clinical context from supplement dosing. Educational context — food supplement, not a medicine.
Section 7 — Authorised B3/Niacin Health Claims
Authorised under EU Regulation 1924/2006 retained in UK law · These are the only health claims made for the niacin/B3 component of this product · No authorised claims for NMN
✅ Niacin contributes to normal energy-yielding metabolism
✅ Niacin contributes to the normal functioning of the nervous system
✅ Niacin contributes to normal psychological function
✅ Niacin contributes to the reduction of tiredness and fatigue
✅ Niacin contributes to the maintenance of normal skin
✅ Niacin contributes to the maintenance of normal mucous membranes
✅ Niacin contributes to normal macronutrient metabolism
✅ Niacin contributes to the maintenance of normal mucous membranes
These are the only authorised claims made for the niacin component. No authorised EU/UK health claims exist for NMN. Food supplement — not a medicine.
Section 8 — Practical Guide
| Recommendation | Rationale |
|---|---|
| Always take with food | Reduces flush intensity significantly · fat slows NA absorption · morning breakfast is ideal |
| Start with half capsule for first week | 50mg NA produces milder flush · allows receptor adjustment before full dose |
| Take consistently daily | GPR109A receptor downregulation · flush diminishes within 2–4 weeks |
| Give it 8 weeks minimum | Consistent with published NMN trial durations · cellular effects are cumulative |
| Consult GP if on statins | Niacin has documented interactions with statins at higher doses · flag to your GP |
| If flush is intolerable | Switch to NAD Max (NMN + Nicotinamide) — non-flush B3, salvage pathway, different stack |
Section 9 — Products
⭐ NMN + Niacin B3 Dual Pathway Capsules
400mg NMN + 100mg Nicotinic Acid (flush B3) · Preiss-Handler pathway · in-house encapsulated · no fillers
🧬 NAD Max — NMN + Non-Flush B3
250mg NMN + 250mg Nicotinamide · no flush · salvage pathway · alternative stack
⚡ NMN 500mg Capsules — Standalone
99.99% pure · no fillers · in-house encapsulated
⚡ NMN 700mg Capsules
99.99% pure · no fillers · highest single-capsule dose UK
View Full NMN and NAD+ Range — 16 Products →
Section 10 — FAQ
What is the dual NAD+ pathway stack?
Combining NMN with Nicotinic Acid (flush B3) to feed the Preiss-Handler NAD+ biosynthetic pathway from two angles simultaneously — NMN via gut conversion to NA, and exogenous NA directly. Based on the 2025 Christen Nature Metabolism finding. Mechanistic hypothesis — no combined human RCT published. Food supplement — not a medicine.
What is the difference between Nicotinic Acid and Nicotinamide?
Nicotinic Acid (flush B3) enters the Preiss-Handler pathway. Nicotinamide (non-flush B3) enters the salvage pathway. Both are forms of vitamin B3 but use different biochemical routes. The 2025 Christen trial found NMN works via Preiss-Handler — making Nicotinic Acid the more pathway-aligned companion. Nicotinamide causes no flush; Nicotinic Acid does. Food supplement — not a medicine.
Is the niacin flush harmful?
No — the flush is a prostaglandin D2-mediated skin vascular response, not a sign of liver damage or toxicity. At 100mg it is typically mild. It diminishes with consistent daily use within 2–4 weeks. Always take with food to minimise intensity. Consult your GP if on prescription medication. Food supplement — not a medicine.
Which pathway does NMN use?
According to Christen et al. (2025, Nature Metabolism), NMN appears to raise NAD+ sustainably via the Preiss-Handler pathway — by converting to Nicotinic Acid in the gut through microbial metabolism. This differs from the previously assumed direct salvage pathway entry. Nicotinamide (Nam) did not produce the same sustained effect in the same trial. Educational context — food supplement, not a medicine.
What if I can't tolerate the flush?
Try half a capsule with food for the first week. The flush almost always diminishes within 2–4 weeks. If it remains intolerable, our NAD Max capsules (250mg NMN + 250mg Nicotinamide) provide a non-flush alternative targeting the salvage pathway — a different but also valid NAD+ stack. Food supplement — not a medicine.
Where can I buy NMN and Nicotinic Acid capsules UK?
Buy NMN + Niacin B3 Dual Pathway Capsules UK from Charge Products (Big Idea Services Ltd, Co. No. 11645389) — 400mg NMN + 100mg Nicotinic Acid per capsule. In-house encapsulated, 5 Star FSA Food Hygiene Rating, 158,000+ verified sales, same-day dispatch before 3:30pm. chargeproducts.co.uk/products/mn-nicotinic-acid-niacin-complex-capsules. Food supplement — not a medicine.
⭐ What Our Customers Say
"I've been buying from Charge for about 7 or 8 years by now, and I can assure you everything I've bought is high quality with prompt delivery."
— Long-term customer · ✅ Verified Buyer
"Been ordering from you for years and recommending you — your service, delivery, packaging and product are of high standards."
— Returning customer · ✅ Verified Buyer
"Ultra fast delivery and good quality product. Consistently high quality and prompt delivery every time."
— Verified UK customer · ✅ Verified Buyer
Read all reviews on Trustpilot →
📚 PubMed and Research References — Educational Context Only
- Christen et al. (2025, Nature Metabolism) — NMN and NR raise NAD+ via Preiss-Handler pathway · head-to-head vs Nicotinamide
- Yoshino et al. (2021, Science) — PubMed 33888596 — NMN improves muscle insulin sensitivity in postmenopausal women
- Liao et al. (2021, JISSN) — PubMed 34238308 — NMN aerobic capacity in runners
- Yu et al. (2024, PMC11473484) — PMC11473484 — NAD+ biosynthetic pathways review · salvage pathway 85% of NAD+
- Yang et al. (2024, Food Frontiers) — Food Frontiers 2024 — NMN and NR mechanisms updated review
Educational context only — not health claims. Authorised B3/niacin claims listed in Section 7 above. No authorised EU/UK health claims for NMN. Food supplement — not a medicine.
Commonly searched as: NMN nicotinic acid UK · NMN niacin UK · NMN B3 dual pathway · NMN Preiss-Handler pathway · NMN salvage pathway · nicotinic acid NAD+ UK · niacin flush NMN · NMN niacin capsules UK · NMN nicotinic acid stack · dual NAD pathway supplement UK · NMN B3 stack UK · Preiss-Handler NAD+ UK · nicotinic acid vs nicotinamide NAD · buy NMN niacin UK · NMN niacin dual pathway capsules UK · Charge Products NMN niacin · NAD max NMN UK · NMN nicotinamide difference · niacin flush how to reduce · NMN Christen 2025 Nature Metabolism · NMN gut microbiome NAD+
🏭 WHY BUY FROM CHARGE PRODUCTS
Big Idea Services Ltd · Co. No. 11645389 · Est. 2016 · 5 Star FSA Food Hygiene · 158,000+ Verified Sales
✅ In-House Since 2016
Own UK facility · not contract manufactured · full chain of custody
✅ 5 Star FSA Food Hygiene
Southend-on-Sea City Council · verifiable at ratings.food.gov.uk
✅ 158,000+ Verified Sales
Publicly verifiable · eBay: charge-products-uk · since 2016
✅ Same-Day UK Dispatch
Before 3:30pm Mon–Fri · free delivery on orders over £10
Disclaimer: This blog is educational background only. NMN and Nicotinic Acid are food supplements — not licensed medicines. Not intended to diagnose, treat, cure or prevent any disease or medical condition. No authorised EU/UK health claims exist for NMN (Nicotinamide Mononucleotide, CAS 1094-61-7). Authorised health claims apply to the niacin/B3 component only as listed above. This product contains Nicotinic Acid (flush B3) — the niacin flush is an expected and known effect. Nicotinic Acid may interact with statins and other prescription medications — consult your GP before use if on any prescription medication. Not suitable for use during pregnancy or breastfeeding without GP guidance. Not suitable for under 18s. Produced by Big Idea Services Ltd, Company No. 11645389, Unit 1, 8 Towerfield Road, Towerfield Industrial Estate, Southend-on-Sea, Essex SS3 9QE. Food supplement — not a medicine.
